BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

500 related articles for article (PubMed ID: 30008306)

  • 1. Supercritical fluid chromatography coupled to mass spectrometry - A metabolomics perspective.
    Shulaev V; Isaac G
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Aug; 1092():499-505. PubMed ID: 30008306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Supercritical fluid chromatography - Mass spectrometry in metabolomics: Past, present, and future perspectives.
    van de Velde B; Guillarme D; Kohler I
    J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Dec; 1161():122444. PubMed ID: 33246285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Supercritical fluid chromatography/mass spectrometry in metabolite analysis.
    Taguchi K; Fukusaki E; Bamba T
    Bioanalysis; 2014; 6(12):1679-89. PubMed ID: 25077627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methods in endogenous steroid profiling - A comparison of gas chromatography mass spectrometry (GC-MS) with supercritical fluid chromatography tandem mass spectrometry (SFC-MS/MS).
    Teubel J; Wüst B; Schipke CG; Peters O; Parr MK
    J Chromatogr A; 2018 Jun; 1554():101-116. PubMed ID: 29699872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Supercritical fluid chromatography-mass spectrometry using data independent acquisition for the analysis of polar metabolites in human urine.
    Akbal L; Hopfgartner G
    J Chromatogr A; 2020 Jan; 1609():460449. PubMed ID: 31443968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimization of a two-dimensional liquid chromatography-supercritical fluid chromatography-mass spectrometry (2D-LC-SFS-MS) system to assess "in-vivo" inter-conversion of chiral drug molecules.
    Goel M; Larson E; Venkatramani CJ; Al-Sayah MA
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 May; 1084():89-95. PubMed ID: 29579733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The combination of four analytical methods to explore skeletal muscle metabolomics: Better coverage of metabolic pathways or a marketing argument?
    Bruno C; Patin F; Bocca C; Nadal-Desbarats L; Bonnier F; Reynier P; Emond P; Vourc'h P; Joseph-Delafont K; Corcia P; Andres CR; Blasco H
    J Pharm Biomed Anal; 2018 Jan; 148():273-279. PubMed ID: 29059617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Supercritical fluid chromatography-tandem mass spectrometry for high throughput bioanalysis of small molecules in drug discovery.
    Zhang X; Ding X; Wang J; Dean B
    J Pharm Biomed Anal; 2019 Feb; 164():62-69. PubMed ID: 30359840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A technical overview of supercritical fluid chromatography-mass spectrometry (SFC-MS) and its recent applications in pharmaceutical research and development.
    Chen L; Dean B; Liang X
    Drug Discov Today Technol; 2021 Dec; 40():69-75. PubMed ID: 34916026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic profiling of lipids by supercritical fluid chromatography/mass spectrometry.
    Bamba T; Lee JW; Matsubara A; Fukusaki E
    J Chromatogr A; 2012 Aug; 1250():212-9. PubMed ID: 22709604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolite analysis by supercritical fluid chromatography.
    Matsubara A; Fukusaki E; Bamba T
    Bioanalysis; 2010 Jan; 2(1):27-34. PubMed ID: 21083114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two-dimensional supercritical fluid chromatography/mass spectrometry for the enantiomeric analysis and purification of pharmaceutical samples.
    Zeng L; Xu R; Zhang Y; Kassel DB
    J Chromatogr A; 2011 May; 1218(20):3080-8. PubMed ID: 21489542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Importance of optimizing chromatographic conditions and mass spectrometric parameters for supercritical fluid chromatography/mass spectrometry.
    Fujito Y; Hayakawa Y; Izumi Y; Bamba T
    J Chromatogr A; 2017 Jul; 1508():138-147. PubMed ID: 28624150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of supercritical fluid chromatography to the analysis of hydrophobic metabolites.
    Bamba T
    J Sep Sci; 2008 May; 31(8):1274-8. PubMed ID: 18384099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances in liquid-phase separations for clinical metabolomics.
    Kohler I; Giera M
    J Sep Sci; 2017 Jan; 40(1):93-108. PubMed ID: 27790840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New insights in pharmaceutical analysis.
    Guillarme D; Schappler J; Boccard J; Veuthey JL; Rudaz S
    Chimia (Aarau); 2012; 66(5):330-4. PubMed ID: 22867546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Supercritical fluid chromatography coupled with in-source atmospheric pressure ionization hydrogen/deuterium exchange mass spectrometry for compound speciation.
    Cho Y; Choi MH; Kim B; Kim S
    J Chromatogr A; 2016 Apr; 1444():123-8. PubMed ID: 27020885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultra-high performance supercritical fluid chromatography hyphenated to atmospheric pressure chemical ionization high resolution mass spectrometry for the characterization of fast pyrolysis bio-oils.
    Crepier J; Le Masle A; Charon N; Albrieux F; Duchene P; Heinisch S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Jun; 1086():38-46. PubMed ID: 29656082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High throughput and exhaustive analysis of diverse lipids by using supercritical fluid chromatography-mass spectrometry for metabolomics.
    Bamba T; Shimonishi N; Matsubara A; Hirata K; Nakazawa Y; Kobayashi A; Fukusaki E
    J Biosci Bioeng; 2008 May; 105(5):460-9. PubMed ID: 18558335
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 25.